Metraipolis › archive › dc_b49cab5dd337
Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41154406
- DOI
- 10.3390/cancers17203349
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:36:24.410Z
- SHA-256 of the archived text
b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd- Stable URL of this page
https://metraipolis.com/documento/dc_b49cab5dd337
How to cite
Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406 — Europe PMC (en), https://europepmc.org/article/MED/41154406 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b49cab5dd337 (Metraipolis archive dc_b49cab5dd337, sha256 b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd)
BibTeX
@misc{dcb49cab5dd337,
title = {Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:41154406},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41154406},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b49cab5dd337; sha256 b579561882c4832322910de67a871821fac8e23993ead0a2c4c7b6255471a4fd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154406. Agents can read the archived copy with the MCP tool read_document.